Socio-Economic Disparities in Access to Diagnostic Neuroimaging Services in the United Kingdom: A Systematic Review by Karia, A et al.




Socio-Economic Disparities in Access to Diagnostic
Neuroimaging Services in the United Kingdom:
A Systematic Review
Aleesha Karia 1, Reza Zamani 1 and Mohammad Akrami 2,*


Citation: Karia, A.; Zamani, R.;
Akrami, M. Socio-Economic
Disparities in Access to Diagnostic
Neuroimaging Services in the United
Kingdom: A Systematic Review. Int. J.
Environ. Res. Public Health 2021, 18,
10633. https://doi.org/10.3390/
ijerph182010633
Academic Editor: Paul B. Tchounwou
Received: 2 September 2021
Accepted: 6 October 2021
Published: 11 October 2021
Publisher’s Note: MDPI stays neutral
with regard to jurisdictional claims in
published maps and institutional affil-
iations.
Copyright: © 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
1 Medical School, College of Medicine and Health, University of Exeter, Exeter EX1 2LU, UK;
ak664@exeter.ac.uk (A.K.); r.zamani@exeter.ac.uk (R.Z.)
2 Department of Engineering, College of Engineering, Mathematics and Physical Sciences, University of Exeter,
Exeter EX4 4QF, UK
* Correspondence: m.akrami@exeter.ac.uk
Abstract: Socio-economic factors affecting health care can lead to delays in diagnosis of neurological
conditions, consequentially affecting treatment and morbidity rates. This inequality in health care can
leave patients from lower socio-economic backgrounds more vulnerable to a poorer quality of care
from health care providers in the United Kingdom (U.K.). Aims: In this systematic review, we assess
the impact of socio-economic status on the use of diagnostic neuroimaging in the U.K., measured
by the timeliness, accessibility and appropriate use of computed tomography (CT), magnetic reso-
nance imaging (MRI), ultrasonography, electroencephalography (EEG) and single-photon emission
computed tomography (SPECT). We specifically evaluate the non-surgical use of neuroimaging
techniques as this relies on the judgment of primary care-givers (e.g., doctors and radiologists),
where health disparities are most common. This study includes the analysis of diagnostic imaging
used for dementia, minor head injury, stroke, cancer, epilepsy, chronic inflammatory demyelinating
polyneuropathy and Parkinson’s disease. With this study, we aim to assess the health inequalities at
disease diagnosis. Methods: Using Medline (via Ovid), PubMed and Web of Science databases as
sources of information, we critically appraise existing studies on neuroimaging use in the U.K. health
care system, published between January 2010 and February 2021. Findings: A total of 18 studies were
included in this research, revealing that there was an increase in patients of Black and Asian commu-
nities diagnosed with dementia and at an earlier age. There was little evidence to suggest that a lack
of access to diagnostic imaging is associated with socio-economic status. However, there are data
to suggest that people of a lower socio-economic background require more specialist services with
diagnostic neuroimaging tools. In addition, there is evidence to suggest that diagnostic neuroimaging
techniques could be utilised more effectively by health care workers to prevent unnecessary delays
in diagnosis for patients in lower socio-economic areas.
Keywords: neuroimaging; health inequalities; BAME (Black, Asian and Minority Ethnic); computed




Neurological conditions can progress rapidly, so an early diagnosis is vital for treat-
ment and survival. It is recognised by the National Health Service (NHS) that delays in
primary and secondary care can lead to a delayed diagnosis, which could have major
consequences for treatment and morbidity rates [1]. In recent years, the knowledge and
awareness surrounding health inequalities have increased. The complex dynamics of the
social determinants has an effect on the timeliness of diagnosis and, consequently, disease
progression [2,3]. In the more diverse and aging population, people are living longer and
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the demographic of patients is continually changing. This means that the prevalence of
neurological diseases is projected to increase alongside the diversity of the aging population
within 10 years [4–8].
Socio-economic status historically categorises social groups into race which is reflected
in the current policies, practices and services affecting health care [9]. Hence, it is critical to
identify the specific aspects of health care that are imbalanced to suggest improvements
that could support Black, Asian and Minority Ethnic (BAME) communities. Whilst primary
care interventions were introduced to increase accessibility to health care, it is reported
that general practitioners (GP) can act as gate keepers to intervention, causing delays in
diagnosis and treatment [10]. Early diagnosis of neuro-disease or trauma is essential to
reduce the risk of morbidity and mortality of patients. Neuro-disease can be degenerative,
such as dementia, with limited treatment options available, meaning that early diagnosis
will allow patients the opportunity prepare and plan their care while they still have the
mental capacity to make decisions [11]. In cases such as tumour growth and minor head
injury, a timely diagnosis would benefit the likelihood of survival and prevent further
neurological damage that could affect the patient’s quality of life.
A systematic review on the utilisation of the neurological care system was conducted
in the United States of America (USA), which concluded that there are inequalities in access
to health care in neurology. The implications of this observed a lack of engagement from
minority communities at low-level treatments and routine appointments. Consequently,
this study reported an overrepresentation of minority communities seeking emergency
care for severe illness. This is not only more costly for the hospital and patient, but
there are greater risks associated with delayed treatment [12]. This research emphasises
the importance of early care and diagnosis to support patients and allow them to make
informed decisions on their care before they lose autonomy over their own health care. It is
suggested that the disparities within neurologic health care was multifactorial and affected
by socio-economic status of patients and a lack of representation in neurology.
As highlighted by the Black Lives Matter movement, racial disparities and health
inequalities in the U.K. are similar to America; therefore, it would be informative to see
if these findings are replicated [13]. Unlike the USA, the U.K. has a public health care
system that intends to mitigate the economic disparities in diagnostic imaging. However,
there are additional socio-economic barriers, other than financial burden, which may affect
accessibility.
This review specifically focusses on highlighting the barriers to timeliness, accessibility
and appropriate use of diagnostic neuroimaging for diseases or conditions as this would
indirectly affect the patient’s treatment and morbidity.
Table 1 provides an overview of current imaging techniques used for the diagnosis of
dementia, minor head injury (MHI), stroke, cancer and epilepsy. Table 2 summarises the
reasons why computed tomography (CT), magnetic resonance imaging (MRI), ultrasound,
electroencephalography (EEG) and single-photon emission computed tomography (SPECT)
may be utilised in diagnosis.
Table 1. Overview of the use of diagnostic neuroimaging techniques in dementia, minor head injury, stroke, cancer, epilepsy,
CIDP and Parkinson’s disease. This table describes the type of neuroimaging technology recommended for use in the U.K.
for the diagnosis of dementia, MHI, stroke, cancer, epilepsy, CIDP and Parkinson’s disease. Recommendations are based on
NHS and NICE guidelines. Information was sourced from various resources [14–21]. Refer to the list of abbreviations.
Head or Brain Condition Diagnostic Imaging Use
Dementia
Patient history and cognition assessments are taken at a primary care service, often
a local GP. They will then refer patients to a specialist service, such a Memory
Assessment Service (MAS) clinic, where further cognition exams and brain
imaging may be taken with either CT or MRI to determine the sub-type of
dementia. Additional imaging tools such as PET, SPECT or EEG may be performed
to rule out any tumours or fluid-build up or create a higher-resolution image.
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Table 1. Cont.
Head or Brain Condition Diagnostic Imaging Use
Minor head injury (MHI) Usually, a CT scan is the most efficient and cost-effective approach to determinethe structure of the brain. MRI provides a higher-resolution image of the tissue.
Stroke
CT or MRI scans are used to classify whether the stroke is ischaemic or
haemorrhagic to identify the treatment pathway and prevent further damage. The
National Stroke Strategy in England advises that patients receive brain imaging
immediately within normal working hours and within 60 min of out-of-hours
service.
Cancer
The “two-week rule” on oral cancer requires that all potential cases of cancer be
assessed by secondary specialist care within 14 days after the referral from primary
care. Imaging may consist of an endoscopy, X-ray, CT, MRI or PET. In addition to
diagnostic imaging, a biopsy may be performed.
Epilepsy
EEG should be performed within 4 weeks of request by a professional. This will
support the diagnosis from clinical presentation. MRI should be the imaging of
choice for the diagnosis of epilepsy to identify gross pathology.




MRI imaging is used to confirm inflammation of nerve roots with the addition of
nerve condition tests and electromyography.
Table 2. Summary of diagnostic neuroimaging techniques.
Type of Neuroimaging Description Advantages Disadvantages
Computed Tomography (CT)
• Measures the absorption
of X-rays




• Low resolution of gross
structures




• Changes in electrically
charged molecules in a
magnetic field
• More precise than X-ray
• Non-invasive
• Very few health risks
associated
• Patient must keep still
Diagnostic Ultrasonography
(Ultrasound)




















• Low spatial resolution
compared to MRI
• Portable






blood flow in the brain
to differentiate active
and non-active areas
• Nuclear imaging does





• Radioactive tracer may
cause bleeding, pain or
trigger allergies
This table describes the reasons particular imaging techniques may be used or suggested for use. Information sourced from various
sources [22–25].
1.2. Objectives
The aim of this study is to examine the characteristics of patients undergoing diag-
nostic neuroimaging across the U.K., including race, socio-economic status and disease
severity, to determine whether there is a significant inequality in access to the required
neuroimaging technology. As quality of health care varies across subpopulations in the
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U.K., we intend to identify where targeted interventions could be implemented to improve
the inequities as well inequalities faced by minority populations [26,27]. This qualitative
study follows the Population, Interest, Context (PICo) format (Table 3).
Table 3. Inclusion and exclusion criteria.




• Memory Assessment Service
clinics
• NHS hospitals
• Private hospitals in the U.K.




• Studies on Children (<18 years
of age)
Interest
• Inequalities in access to
diagnostic neuroimaging
services
• Biomarker detection in the
blood
Context




• Studies conducted in England,
Scotland, Northern Ireland and
Wales
• Studies without U.K.-based
data
Study design • Cohort studies • Non-English studies• Studies published before 2010
Our study follows the Population, Interest, Context (PICo) format.
2. Materials and Methods
The methodology of this systematic review follows the PRISMA-DTA guidelines for a
systematic review and meta-analysis [28].
2.1. Eligibility Criteria
Table 3 shows the study characteristics that are eligible for review. The study design
follows the PICo format for a qualitative systematic review.
Population: This study investigated all adult patients eligible or having undergone
diagnostic head or brain imaging techniques to identify the differences in access to dif-
ferent imaging techniques. We excluded studies on autism, mental health and biomarker
screenings on blood samples to focus on structural and functional imaging techniques.
Studies of neurodevelopmental disorders were also excluded as they did not test on an
adult population.
Interest: As this is an observational study to see if there are any health inequalities
at the stage of diagnosis, we searched for cohort studies, systematic reviews and meta-
analysis with primary data on diagnostic neuroimaging. Studies that had no relevant data
in relation to access to diagnostic imaging on the head or brain were also excluded. Those
that discussed other measures of cognitive screening as a measure of illnesses that are
diagnosed with imaging techniques were also included to look at a quantitative measure
of disease progression at diagnosis despite imaging not being mentioned in the study.
Context: Although the NHS provides services that should be accessible to all patients
in the U.K., wed looked into the time taken for diagnosis and disease progression at
diagnosis to observe any differences in care based on socio-economic status that would
affect morbidity and mortality rates of patients. All studies on health care providers with
access to diagnostic imaging will be included in this study. This means that data on private
practices will also be included as the patient socio-economic characteristics may vary. This
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systematic review focuses on complete studies published between 2010 and 2021 to limit
the search to the most recent data to determine any inequalities in the current health care
system. As the study was based in the U.K., papers that were non-English and published
outside of the U.K. were excluded. This study also takes into account the use of Clinical
Commissioning Groups (CCG), which were introduced to the NHS system in 2013 and
are responsible for primary care within local areas [29]. Service provided for each area is
dependent on the demand, which means that access to specialised services varies across the
U.K. Therefore, the outcomes of this study will allow for targeted interventions to improve
health systems for subpopulations [26].
2.2. Search
The search process was carried out on several dates from 10 January 2021 until the
final search on 10 July 2021. Data were collected from the Ovid (MEDLINE), PubMed, and
Web of Science databases using the following search terms combined:
1. clinical commissioning groups;
2. refer/referral/referred;
3. United Kingdom OR England OR Wales OR Scotland OR Northern Ireland OR Great
Britain OR GB OR UK;
4. ethnic * or equal * or inequal * or Black Asian Minority Ethnic;
5. head or brain or neuro *;
6. not neurodevelopmental;
7. imaging or imag * or diagnostic imaging or diagnos *;
8. sense or sensory or sensation;
Table 4 details the line-by-line advanced searches with Boolean operators used for
each database search. With the Ovid search terms, “.mp” was added to terms 3, 6 and
7 to ensure a multi-purpose search was carried out and these terms were included in
the title and/or abstract of the article, refining the search further. “*” and “$” were used
to expand the search for changes in suffixes of the word. The searches were limited to
publication between January 2010 and February 2021 to gather the most recent articles that
are a reflection of the health care system at the time this systematic review was conducted.
The databases were also limited to English articles only, as stated in the eligibility criteria.
Table 4. Line-by-line search advance search history.
Ovid (MEDLINE) PubMed Web of Science
Search terms 1
1. (United Kingdom or England or
Wales or Scotland or Northern
Ireland or Great Britain or GB or
UK) .mp.
2. (access $ or inequality $ or equal
$) .af.
3. limit 2 to abstracts
4. (minority or ethni $ or BAME or
socio-economic) .af.
5. (head or brain or neuro $) .mp.
6. limit 5 to abstracts
7. limit 6 to yr = “2010-Current”
8. (imaging or diagnos $ or MRI or
CT or CAT or PET or fMRI or
ECG) .mp.
9. limit 8 to abstracts
10. 1 and 3 and 4 and 7 and 9
(United Kingdom or England
or Wales or Scotland or
Northern Ireland or Great
Britain or GB or UK)
AND
(imaging or diagnos *)
AND
(access * or inequality * or
equal *)
AND
(minority or ethni * or BAME
or socio-economic)
AND
(head or brain or neuro *)
CU = (United Kingdom or
England or Wales or Scotland
or Northern Ireland or Great
Britain or GB or UK)
AND
TS = (imaging or diagnos *)
AND
KP = (access * or inequality * or
equal *)
AND
(minority or ethni * or BAME
or socio-economic)
AND
KP = (head or brain or neuro *)
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Table 4. Cont.
Ovid (MEDLINE) PubMed Web of Science
2
1. (United Kingdom or England or
Wales or Scotland or Northern
Ireland or Great Britain or GB or
UK) .mp.
2. (access $ or inequality $ or equal
$) .af.
3. limit 2 to abstracts
4. (minority or ethni $ or BAME or
socio-economic) .af.
5. (head or brain or neuro $) .mp.
6. limit 5 to abstracts
7. limit 6 to yr = “2010-Current”
8. (imaging or diagnos $ or MRI or
CT or CAT or PET or fMRI or
ECG) .mp.
9. limit 8 to abstracts
10. 1 and 3 and 4 and 7 and 9
11. (“Clinical Commissioning
Groups”) AND (refer *) .mp.
(ethnic * or equal * or inequal
* or Black Asian Minority
Ethnic)
AND
(referral or referred or refer)
AND




(United Kingdom or England
or Wales or Scotland or
Northern Ireland or Great
Britain or GB or UK))
AND
(head or brain or neuro *)
AND
(refer or referral or referred)
NOT (neurodevelopment *)
(“Clinical Commissioning
Groups”) AND (refer *)
Filters applied From 2010 to 2021English
Full text
From 2010 to 2021
From 2010 to 2021
English
Af = all fields; mp = multi-purpose search; “*” and “$” indicate truncation, searching for variation of suffixes and prefixes. TS = topic; CU =
country/region; KP = keyword plus. ‘AND’ and ‘OR’ Boolean operators were applied to combine searches, refining the database further.
The same terms were used on each database for consistency. All searches were filtered for publication dates between 2010 and 2021. Where
applicable, “English” language was selected.
Search number 3 included all research conducted in the U.K., search 2 explored diag-
nostic imaging techniques, search number 4 collected any data based on racial inequalities
or socio-economic deprivation, as both are associated and often mentioned together, and
search 5 refined the searches to look at neuro-related diseases or impaired function.
All searches were then exported from the databases to the Rayyan web-tool (https:
//rayyan.ai/) accessed on 7 April 2021. which detected duplicates between databases so
that they could be removed. The inclusion and exclusion process is visually represented in
Figure 1.
The dashed lines symbolise the removal of studies and the arrows represent the
studies moving forward after each stage of the review. After the search terms were applied
to the databases, a total number of 402 studies were suggested for this review. Duplicate
studies were removed and abstracts and titles were screened and the remaining papers
were kept for review. Those unsuitable were removed and 68 studies were reviewed for
data eligibility. A total number of 18 studies were suitable as per the inclusion/exclusion
criteria.
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and exclusion criteria detailed in Table 2. Following this, the remaining studies were read 
and screened for any relevant data and findings on inequalities in access to diagnostic 
neuroimaging. While imaging type is important to the finding of this research, if it was 
not directly mentioned or measured, papers that reported other measures of disease pro-
gression and potential disparities with relevant findings were still included. This inclu-
sion and exclusion criteria were based on the NICE guidelines for dementia, as it is as-
sumed that data on diagnosis of these diseases would not be available without the use of 
diagnostic imaging [30].  
Data from selected papers were collected by one reviewer and any discrepancies 
were discussed with two other independent reviewers (R. Zamani and M. Akrami). Where 
information was unclear, authors of the relevant article were contacted for clarification on 
Figure 1. Flo chart to sho the inclusion and exclusion of st ies.
2.3. Study Selection
The first stage of selection included screening the titles and abstracts of articles to
decide if the articles could be a relevant contribution to the research using the inclusion
and exclusion criteria detailed in Table 2. Following this, the remaining studies were read
and screened for any relevant data and findings on inequalities in access to diagnostic
neuroimaging. While imaging type is important to the finding of this research, if it was
not directly mentioned or measured, papers that reported other measures of disease
progression and potential disparities with relevant findings were still included. This
inclusion and exclusion criteria were based on the NICE guidelines for dementia, as it is
assumed that data on diagnosis of these diseases would not be available without the use of
diagnostic imaging [30].
Data from selected papers were collected by one reviewer and any discrepancies were
discussed with two other independent reviewers (R. Zamani and M. Akrami). Where
information was unclear, authors of the relevant article were contacted for clarification on
data interpretation. Where data were missing for dates, it was assumed that data were
collected close to the time of submission for peer review.
The data outcomes in Table 4 display the data collected from each paper. The year
of study is reflective of how accurate the study reflects the current health care system, as
regulations and laws are regularly updated in order to improve patient experience and
financial burden. Both type of imaging and location of study were reported as these have
an effect on the study conclusion. The source of the data reported and interpreted was
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reported, as some studies use the same database and therefore, their findings may be
similar for that reason.
2.4. Risk of Bias
There is a risk of bias from individual studies included in this systematic review
with the selection of hospital locations and patient data collection. This was mitigated
by assessing the risk of bias with individual journals by reporting the journal publication
ranking using SCIMago Journal Ranking tool (https://www.scimagojr.com/), accessed on
3 March 2021. This ranked the journals into quartiles, 1 being of the highest quality and 4
being the lowest. This is a strong indication of the impact factor of a paper, as the more
people that are subscribed to a journal, the higher likelihood of the research being seen and
cited [31]. The journal ranking was used after the inclusion and exclusion criteria to assess
the quality of the papers included. Papers with a “Q4” ranking were excluded and those in
the “Q3” ranking were assessed based on the value of the information in the paper.
3. Results
3.1. Search Results
The search of the PubMed, Ovid and Web of Science databases produced 339 articles,
of which 62 were duplicates. After removing duplicates, 277 articles were screened for
title and abstract using the eligibility criteria of inclusion and exclusion. This refined the
studies to 51 potentially useful studies that could inform the research. Figure 1 outlines the
number of sources eliminated after each review process and highlights the characteristics
of those excluded from the review. Studies that did not use structural or functional imaging
techniques, studies exploring inequalities in mental health care or pharmacotherapy, studies
using animal models and ineligible study designs were excluded after review. After reading
all articles available in full, only 18 studies were included in the final study selection with
data relevant to the research question.
3.2. Study Characteristics
Eighteen papers were eligible for this systematic review. Their study characteris-
tics and conclusions are detailed in Table 5. Figure 2a highlights the number of papers
discussing each type of imaging. Approximately 31% of the studies discuss the use of
CT. Figure 2b shows the distribution of studies included on each neurological condition.
Approximately 38% of the studies (7/18) focused on the prevalence of dementia, while
only one study discusses epilepsy.
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-68.3% of patients had an alternative pre-
referral diagnosis  
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-Poor electrophysiological records show 













-PD sleep scale 
NHS 
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gist, showing that there is not equal ac-
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-Lower education was used as a predic-
tor of PD 
‘-’ = missing data  
This summary reports on year of study as a measure of how accurately reflects on the current health care system. The data 






Figure 2. Pie charts representing the distribution of data collected. (a) This pie chart represents the 
distribution of data collected on neuroimaging techniques. Approximately 31% of studies reported 
on CT imaging techniques, 44% of studies did not mention imaging directly and ultrasound and 
EEG were only mentioned in one study each. This shows that there are not enough data available 





Type of Diagnostic Neuroimaging Studied 








Head or Brain Condition 
Dementia Minor Injury Stroke
Cancer Epilepsy CIDP
Parkinson's Disease
Figure 2. Pie charts representing the distribution of data collected. (a) This pie chart represents the
distribution of data collected on neuroimaging techniques. Approximately 31% of studies reported
on CT imaging techniques, 44% of studies did not mention imaging directly and ultrasound and
EEG were only mentioned in one study each. This shows that there are not enough data available on
ultrasound and EEG imaging and this should be considered for an area of further research. (b) This
pie chart represents the distribution of data collected on neurological conditions. Approximately
37% of the studies presented data for dementia, showing that there is more research available on the
health inequalities in dementia, while only one study reported on the accessibility of ultrasound and
EEG imaging.
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Table 5. Summary of results.
Condition Reference Year ofStudy Journal Rank (SJR) Type of Imaging Location of Study Data Collected Source Study Conclusion
Dementia










female, non-White and most
deprived were more likely to
have lower cognitive function
at diagnosis








-Vascular dementia is more
common in black patients
-Black patients were more likely
to present with psychotic
symptoms while South Asians
were more likely to show
depressive symptoms










-Association of cognitive score
at diagnosis and
ethnicity—mental state of at
diagnosis was lower for Asian
and Black patients compared to
White patients
-Association between age at
diagnosis and ethnicity—Asian
and Black patients were
diagnosed about 4 years earlier
in age compared to White
patients
[34] 2008 Q1 N/A Greater Manchester
-Age
-GP ownership
-Referrals to secondary care
-IMD
Primary Care Trusts





deprivation and number of
GPs—higher rates of patients
diagnosed with dementia in
multi-handed practices in areas
of greater socio-economic
deprivation.
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Table 5. Cont.
Condition Reference Year ofStudy Journal Rank (SJR) Type of Imaging Location of Study Data Collected Source Study Conclusion
Dementia














-From the U.K., only Northern
Ireland refers to migration in
the dementia guidelines
-MMSE diagnostic tests are not
culturally sensitive to language
barriers
-Language should factor into
diagnosis of dementia








-Translation services offered at
MAS clinics vary around
England and Wales
-There are cognitive testing
limitations with a patient
language barrier









when compared to previous
research
-There were fewer referrals
than expected for some areas of
London
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Table 5. Cont.
Condition Reference Year ofStudy Journal Rank (SJR) Type of Imaging Location of Study Data Collected Source Study Conclusion
MHI







-Most hospitals in England and
Wales report following the
NICE guideline and have
unrestricted access to CT
imaging
-Observations and admissions
of patients are mainly overseen
by senior or specialist staff









deprivation score and head CT
scan—people from more
deprived areas required more
head CT scans
-Association between
deprivation score and age of
the scan—younger people from
more deprived areas were
needing more CT scans








Harnen, S.E. et al., 2010
-It is more cost-effective to
provide CT imaging for
patients before discharge to
avoid later cost of serve illness
or disease.
-For MHI, there should be
unrestricted access to CT
-Risk of cancer increases with
age, giving an estimate of 0.002
for those at 75 years old
[41] 2012 Q2 CTMRI England and Wales
-MRI service hours
-Radiographer’s training NHS trusts
-Only 14% of NHS trusts have
out-of-hours access to MRI
imaging
-1/3 trusts provided the basic
MRI training for non-MRI
radiographers
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Table 5. Cont.
Condition Reference Year ofStudy Journal Rank (SJR) Type of Imaging Location of Study Data Collected Source Study Conclusion
Stroke








-Only 35% of emergency stroke
admissions receive a brain
imaging scan immediately
-16% do not receive imaging
within period of hospital
admission
-Patient characteristics with a
higher likely hood of receiving














-volume of work, capacity,










-CT was used as the main brain
imaging technique in 84%
clinics
-51 clinics utilised MRI for
stroke prevention
-Waiting time for MRI after CT
was about 1 month for 47% of
the clinics
-After a few days, TIA/minor
stroke patients are unlikely to
resent with signs of ischaemia
with MRI, leading to a
misdiagnosis and therefore,
wasting the MRI.
-Nurses with no specialist
medial knowledge were in
charge of medical assessment
at 28% of centres
Int. J. Environ. Res. Public Health 2021, 18, 10633 14 of 27
Table 5. Cont.
Condition Reference Year ofStudy Journal Rank (SJR) Type of Imaging Location of Study Data Collected Source Study Conclusion
Cancer









-Patients from more deprived
areas had a higher rate of late
tumour presentation at
diagnosis
-The introduction of a
“two-week rule” in order to
receive a faster diagnosis has
seen improvement in the
disease presentation at
diagnosis; however, there is
still a greater disease
progression within more
deprived patients








-Medical and dental history











–Those in lower socio-economic
groups had higher hospital
admissions










-33% if the NHS trusts had
access to continuous EEG
monitoring
-2/18 trusts with access to EEG
used it as soon as convulsive
refractory status epilepticus
began
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Table 5. Cont.
Condition Reference Year ofStudy Journal Rank (SJR) Type of Imaging Location of Study Data Collected Source Study Conclusion













records show weakness in
patient care
Parkinson’s







-9% of patients had never seen
a neurologist, showing that
there is not equal access to
specialist services
-Lower education was used as a
predictor of PD
‘-’ = missing data
This summary reports on year of study as a measure of how accurately reflects on the current health care system. The data are categorised into types of neurological condition: dementia, MHI, stroke, cancer and
epilepsy. Refer to the list of abbreviations.
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3.3. Risk of Bias
Most of the studies (17/18) were published in journals with a ranking of Q2 or higher.
Missing data on other types of imaging and neurological conditions mean that the focus of
our study explores the inequalities in the use of CT, MRI, ultrasound and EEG in diagnosing
dementia, MHI, stroke, cancer and epilepsy.
3.4. Result of Individual Studies
3.4.1. Dementia
All (100%, 7/7) of the studies reporting on dementia use cognitive function as a
measure of quantitative disease progression and three of these studies use Index of Multiple
Deprivation (IMD) as a measure of deprivation. Tsamakis et al., 2021, reported that mean
IMD scores were slightly higher for Black African (32.1; SD 8.6) and Caribbean (31.4; SD
9.0) patients, although this was not a significant difference between the IMD scores of
White British patients (26.1; SD 11.4) [5]. T. Schmachtenberg et al., 2020, reported that
only Northern Ireland’s legislations on dementia take ethnicity, cultural and religious
differences into consideration for cognitive testing. It is suggested that Mini-Mental State
Examination (MMSE) does not take into account language barriers. The legislation also
highlighted the increased prevalence of vascular dementia in African, Caribbean and Asian
communities [20]. This is supported by a study looking into the prevalence of dementia in
BAME communities [5]. The study found that African and Caribbean patients had odds
ratios of 1.96 (95% CL 1.56–2.49) and 1.65 (95% CL 1.93–1.75), respectively, when compared
to White British patients. This study also reported that Black African (19.9%; 62/310) and
Caribbean (14.4% 239/1661) and Irish (14.5%; 91/626) patients were the most likely to
experience living condition problems, whilst South Asian patients were the least likely
(5.8%; 21/364).
Brown et al., 2021, reported that the number of ethnic minority referrals was higher in
half of the clinics surveyed (4/8) in Greater London, which saw >50% of ethnic minority
patient referrals [36]. This was representative of the population in Greater London, which is
made up of 55.1% ethnic minorities. Multiple studies reported an earlier age of dementia di-
agnosis and lower cognition assessment scores at diagnosis in ethnic minority communities.
Mukadam et al., 2019, reported that the mean MMSE scores were lower for Asian patients
(−1.25; 95% CL-1.79—0.71: n = 642) and Black patients (−1.82; 95% CL −2.13—1.52: n
= 2008) when compared to White patients [33]. The results showed that Asian patients
were, on average, 4.27 (95% CL 3.61–4.92) years younger at diagnosis and Black patients
were 3.70 years younger (95% CL 3.27–4.13) than White patients. A study reported that
although there were higher rates of dementia diagnosed in areas of lower socio-economic
status (Wald Chi-square = 123.7, p < 0.001), there was still an under diagnosis of patients as
the rates of diagnosis were under the estimated prevalence, showing that, on average, 27
patients (95% CL 22–23) remain undiagnosed for a practice size of 5269 [34]. In addition to
these factors, delays also occur due to a lack of referrals at primary care. The data presented
by Cook et al., 2018, highlight that referrals for BAME patients are significantly lower [37].
BAME patients have a referral Odds Ratio of 0.9 (p < 0.0001) when compared to White
British patients.
3.4.2. Minor Head Injury
Pearce et al., 2012, reported that there was a significant association between the age
of a patient and the Townsend deprivation quantile [39]. Younger patients from more
deprived areas are receiving CT imaging (p < 0.0001). A higher proportion of patients
from areas of higher deprivation had fewer scans; however, this trend was not significant
(p > 0.05). An association between head and neck CT examination and deprivation was
reported (p < 0.0001), showing that people of lower Townsend scores were more likely
to receive imaging for issues within the head and neck. The trend in younger patients
receiving CT imaging was more likely due to injury. Holmes et al., 2012, found that the
mean cost of providing a CT scan for all patients with minor head injury (GBP 2928) is
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cheaper than the mean cost of discharging all patients aged 40 (GBP 3305) [40]. A similar
beneficial trend is seen with the Quality Adjusted Life Year (QALY), as providing imaging
to all patients aged 40 (18.6897) is greater than discharging all patients (18.6669). With
patients aged 75, there is also a benefit seen in the mean cost analysis of providing a CT scan
for all (GBP 1574) compared to discharging patients (GBP 1718). This evidence proves that
it would be more cost-effective to provide patients with a form of neuroimaging to prevent
further damage and cost despite the fact that it is not accessible. A study conducted on CT
access within hospitals in relation to minor head injury reported that only 3.4% (6/174) of
hospitals in their survey did not have unrestricted access to CT technology; however, most
patient admissions required approval by a senior or specialist doctor (119/174; 68.3%) [26].
3.4.3. Stroke
Despite being a mandatory process after being admitted to hospital post-suspected-
stroke, it is reported that in 2008/09, only 34.7% (25,452/7339) of patients received a CT or
MRI scan immediately [14]. This study also reported that 59.0% (43,267/7339) of patients
were seen within one day of admission and 84.3% (61,798/7339) of patients were given
imaging within their stay at the hospital. It was found that there was association between
socio-economic deprivation and likelihood of receiving a brain imaging scan (OR 0.94; 95%
Cl 0.89–0.99, p < 0.05) when compared to the least deprived. Similarly, Hauptfleisch et al.,
2013, reported that 15/107 (14%) had the required access to MRI, whilst extended weekday
access and regular weekend availabilities were offered in 67 and 87 trusts (63% and 81%),
respectively [41]. Further supporting this finding, Brazzelli et al., 2013, reported that 31%
(35/114) of the clinics surveyed reported access to a stroke clinic every day, with an average
of 35% (140,000/400,000) of the Transient Ischaemic Attack (TIA) and stroke patients being
seen within 24 h of admission [42]. This survey also reported that CT imaging was the main
brain imaging technique used in 84% (98/114) of the clinics and only 51% (58/114) used
MRI for stroke assessments. It was reported that 22% of brain imaging results took more
than 2 days to be returned to the stroke service, accounting for further delays in treatment.
Moreover, 95% (95/100) of the clinics surveyed in this study reported the usage of Doppler
ultrasound (DUS) for carotid/vertebral imaging, with 80% reporting that results were
provided on the same day. The DUS exam was followed by a repeat exam (19%; 19/99), CT
(60%; 60/99) or contrast MRI (41%; 41/99) as a confirmation of diagnosis.
3.4.4. Cancer
Langton et al., 2019, found that there was an association between deprivation and
tumour presentation at diagnosis [15]. The level of patients presenting with late stage 3
or 4 oral cancer decreased in areas of increased deprivation between the reported years
1992–2000 (56%; 95% CI 48.7–62.5%; 118/212) and 2001–2012 (47%; 95% CI 42.2–51.2%;
233/499). Whilst this difference was found to be a significant (Chi squared p < 0.03),
inequality remains between the more deprived group and least deprived groups in 2001–
2012 (42%; 95% CI 37.5–46.3%; 211/504). There was also found to be an association between
the location of oral cancer and deprivation, as 56% (236/425) of patients presenting with
tumours on the floor of the mouth were from more deprived areas. Conway et al., 2010,
reported an association between education, gender and Upper Aerodigestive Tract Cancer
(UATC) [43]. Those with a tertiary (university level or equivalent) level of education were
less likely to be diagnosed with UATC in Glasgow (26.1%; 23), Manchester (33.3%; 49) and
Newcastle (27.6%; 24). If patients had a secondary level of education, they would have
greater chances of being diagnosed with UATC in Glasgow (73.9%; 65), Manchester (66.7%;
98) and Newcastle (72.4%; 63). It was also reported that in the British Isles, men had greater
Odds Ratios for developing UATC at the lowest level of education when compared with
those who had a tertiary level of education (19.88; 95% Cl 2.55,154.94, p < 0.01).
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3.4.5. Epilepsy
Patel et al., 2015, reported that 33% of U.K. NHS trusts surveyed in the study had
continuous access to EEG monitoring, while only 3% (2/18) of the trusts utilised the
imaging technique at early signs of Convulsive Refractory Status Epilepticus (CRSE) [44].
This was despite EEG being recognised as a fundamental practice by NICE [16].
3.4.6. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Some 68.3% (41/60) patients were incorrectly diagnosed after initial consultation,
which resulted in delays of treatments [45]. The average delay time for the final diagnosis
of CIDP for patients was 21.3 months (range: 2–132 months).
3.4.7. Parkinson’s Disease
This study concluded that there were no gender differences for referral rate of PD
(p > 0.5) [46]; however, those who were older at GP consultation were less likely to have a
specialist neurology consultation (p < 0.005). Moreover, 37.6% of diagnoses were made by
GPs. Delays between the initial diagnosis and consultation were over a year.
4. Discussion
4.1. Dementia
Some 37% of the studies account for data on socio-economic differences in dementia
care, demonstrating that there are inequalities in the prevalence of disease amongst minority
communities. Studies highlight that Black and Asian patients face a greater risk of being
diagnosed with dementia. The data show that there is a higher occurrence of vascular
dementia [5,33]. This can be explained by the increased risk of hypertension in these
communities, which causes a reduced blood flow to the brain [47,48]. These studies also
emphasised the threat of earlier onset disease. Asian patients were diagnosed at an average
of 4.27 years earlier than White British patients and Black patients were diagnosed at an
average of 3.70 years younger [5,33]. Earlier prevalence of disease could be attributed
to other social determinants of health faced by minority communities, such as diet and
education [49].
Although Mukadam et al., 2019, reported a difference of 3.70 years in Black patients,
other literature estimates that patients of African and Caribbean descent are reported to
show signs of dementia at an average of 7.8 years earlier than White British patients [50].
This could suggest that the data collected by the Clinical Record Interactive search were
only representative of London, where the population of Black communities is greater;
therefore, the health inequalities faced by communities have a different impact. However,
this could also indicate why Black patients appear to have a lower cognitive score at
diagnosis, signifying higher rates of disease progression. In addition to this, it could
signify the lack of referral rates. This is because older literature indicates that there is a
smaller ethnicity difference recorded when there are fewer referrals of BAME populations
reported [37]. This could be an alternative suggestion for the difference in age at diagnosis
reported within this study.
Cognitive function recorded by Mini-Mental State Exams (MMSE) suggested that
disease progression was significantly higher at diagnosis of dementia in Black patients
(−1.82; 95% Cl −2.13 to −1.52) [33], proposing that there was a delay in receiving a
diagnosis. This may be due to the differences in disease presentation between ethnicities.
Black patients have reported higher rates of psychotic symptoms [5]. The misconceptions
surrounding mental health in African communities may prevent patients and their families
from seeking medical attention [51,52], Help-seeking, due to the stigma surrounding
dementia, may also be an issue amongst South Asian [53] and Chinese communities [54],
At diagnosis, ethnic minority patients are more likely to be in crisis and at a worse state
of mental health, triggering help-seeking behaviour [5], again contributing to the lower
cognitive scores recorded at diagnosis.
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Furthermore, the variation of symptoms could be misdiagnosed or ignored at primary
care [55]. As local GP’s act as gate keepers to specialist services, they may allow their own
bias, stereotyping and clinical uncertainty to affect their judgment [12]. Considering that
referrals are dependent on the quality of primary care within one’s local area, this would
suggest an explanation for the association between lower IMD scores and an increased
prevalence of disease. The IMD scores collected also indicate that patients from Black
African and Caribbean backgrounds live in more deprived areas then those who are White
British (p < 0.001) [5]. The increased prevalence of disease supports the finding that there is
poorer health in migrant communities living in areas of more deprivation [56].
The under-diagnosis of disease of BAME patients highlighted by Cook et al., 2018,
is supported by the lack of referrals in areas of lower socio-economic status, highlighted
by Connoly et al., 2011, due to the fewer GP practices in areas of lower SES [34,37]. Al-
though the study on GP practices was in 2011, before CCG came into action, recent data
have highlighted that there are fewer GP practices per 100,000 patients in more deprived
areas [57].
While the use of MMSE allows for quantitative comparison of disease progression, the
Northern Ireland Legislations have recognised that MMSE does not take language barriers
and cultural differences into account. Therefore, it may not be an accurate measurement for
cognition at diagnosis [35]. The addition of translators and varied testing materials could
skew the results, favouring the notion that minority communities have lower cognitive
scores at diagnosis. This insight into testing emphasises the important use of imaging for
diagnosis, as there are no language barriers affecting the results.
Despite the universal use of diagnostic imaging, the need for interpreted materials
is still vital for patient engagement and comfort. A study found that these services were
inconsistent across Memory Assessment Service (MAS) clinics in England and Wales,
which reflected on the patient experience [36]. Clinics with a diverse workforce have
proved to be the most effective, as this increases cultural sensitivity towards the patients of
ethnic minorities and means that the staff can act as translators where appropriate. These
clinics are often in regions of the U.K. where there is a diverse population, suggesting
that the staff and inclusion of patients is reflective of the MAS location. In the event that
translators are not available or cancelled appointments, new appointments are scheduled.
This would have an impact the timeliness of the diagnosis, and, therefore, indirectly affect
the treatment outcome. This research is similar to the systematic review conducted in the
U.S. on neurology services, which found that clinics with a diverse workforce are successful
in engaging with minority communities [12]. Overall, there was no conclusive evidence of
a lack of accessibility to diagnostic imaging itself; however, patient experience could be
improved by exploring the possibility of mitigating language barriers.
4.2. Minor Head Injury
A study examining the use of CT scans in the North of England establish that there
was a greater use of CT neuroimaging in young adults in the most deprived areas [39]. This
is most likely associated with the increased risk of injury through lifestyle exposures. This
includes occupational hazards causing an increased risk of accident from labour-intensive
jobs [58].
The data used in the study were collected from public NHS hospitals. Hence, they may
only provide an overview of essential uses of diagnostic imaging and not precautionary
uses. CT imaging has been proven to be cost-effective; therefore, it is understandable that it
would be the first use of imaging for MHI in public hospitals. Treating severe trauma as a
result of delays may cost the NHS more in treatment [40]. However, utilisation of different
imaging techniques may occur in the private health care sector due to radiation exposure;
patients who have the choice of private care may opt for MRI scans that offer less radiation
exposure. Therefore, it is possible that this study conducted in NHS hospitals only accounts
for the increase in CT scans being performed on patients from higher deprivation levels.
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A limitation of studies using Townsend scores as a measure of deprivation is that they
disregard distance as a factor in access to specialist imaging. Townsend scores are based on
residential post-code. While this is a barrier in receiving diagnostic imaging and specialist
care, it is an issue that may that also affect those living in rural areas of England, which are
not considered as deprived areas [32,39]. A better indication of deprivation would be to use
the Index of Multiple Deprivation as this includes a “health and disability” division. This
would take occupation, income and education into consideration rather than just basing it
on location.
A study suggested that patients with lower IMD scores had fewer scans then those
from less deprived areas [39]. This evidence suggests that differences in access to imaging
could be a result of hospital workload or the judgment of health care workers. This is
because offering liberal use of CT imaging is more beneficial and cost-effective [40].
4.3. Stroke
NICE guidelines for stroke care suggest that MRI imaging should be conducted on
the same day of hospital admission to determine the pathology [59]. Any further delays
in MRI would decrease the value of imaging, as TIA and minor strokes are unlikely to be
detected after a few days of the incident. Therefore, usage would be inappropriate and not
cost-effective. Despite this, it is reported that only 35% of patients were seen within 24 h
of admission. Further delays were accounted for by the delivery of imaging results; 22%
(25/114) of centres surveyed in this study reported that it took longer 2 days to receive
patient results [42].
In addition to this finding, the study reported that CT was routinely used as the main
from of TIA detection in 84% (98/114) of clinics surveyed [42]. This opposes the NICE
guidelines, which state that CT should only be used if there is a doubt of TIA diagnosis [50].
Clinicians may opt for CT imaging, as it is cheaper; however, this may not be the most
beneficial to patients [60]. In this case, those who can afford private care or have a higher
level of education may request an MRI. Hence, education and income would act as a barrier
to imaging services. There was no mention of the utilisation of ultrasound reported by the
NICE guidelines, suggesting that it may not be a form of essential imaging. However, it is
reported that 80% of clinics provided results the same day with this imaging technique [38],
showing that its use is effective for quick diagnosis.
Since there is limited use of out-of-hours services, increasing the availability may
relieve the pressure on MRI clinics [41], meaning that the scans are more accessible when
needed. Out-of-hours services are essential for meeting the targets of stroke care and
prevention; it is suggested that patients receive a scan within the hour of admission into
hospital [14]. Those who are young (p < 0.001), male (p < 0.012) and with a higher SES
(p < 0.001) are more likely to be offered a CT or MRI scan [14], suggesting that there may
inequalities in relation to access to diagnostic imaging for stroke care as it would be based
on professional opinion. This study also saw a relation to patients with fewer comorbidities
(p < 0.001) having a greater chance of imaging. Patients from ethnic minorities are more
likely to have comorbidities [61]; therefore, they may receive fewer imaging opportunities.
Both of these studies conducted on the utilisation of neuroimaging in stoke care were
conducted via anonymous surveys, which meant that it is not possible to see if service is
dependent on the location of clinics [41,42]. Further research should be conducted reporting
the patient demographics receiving the additional or required diagnostic imaging for stoke
prevention. This will allow for the comparison of patient characteristics that could cause
concern for bias in the choice of the patient receiving scans.
4.4. Cancer
Both studies documenting the association between tumour presentation and depriva-
tion reported that people from areas of greater deprivation were diagnosed more frequently
with late stage 3 or 4 UATC [15,43]. Although the gap between the more deprived and
least deprived has decreased since the introduction of the “two-week rule”, there are still a
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greater number of patients in low socio-economic areas being diagnosed with late stage
oral cancer [15]. Prevalence of disease recorded was greater in in areas of lower IMD
scores [15]. This may be due to the social determinants of health affecting overall lifestyle
choices. It is suggested that this increased prevalence amongst those with lower education
is due to lifestyle choices. Lower levels of education are associated with risky behaviours
such as alcohol intake, smoking and insufficient hygiene [43,62].
The additional cost of dental treatments in the U.K. [63] may deter patients and reduce
engagement at primary care. This may factor into delays in referral and diagnosis, mean-
ing that patients present with later stage tumours. In addition, education surrounding
oral hygiene and symptoms may deter patients from help-seeking [64]. Bird et al., 2020,
provided evidence that oral gastrointestinal endoscopy was inefficient to diagnose and con-
cluded an investigation of pharyngolaryngeal cancers as 42.3% of cases were not identified,
while 23.5% of esophagogastric cases were misdiagnosed [65]. Effective diagnosis requires
strong communication between specialties, which further provides evidence that there is a
potential weakness at the referral stage. This means that patients are at risk of misdiagnosis
if the GP does not refer them to the correct secondary care, or if there are delays at this
stage. This study also proposes that inter-specialty referral should be increased to reduce
risk of delays.
4.5. Epilepsy
The study assessing EEG stated that the lack of access to EEG monitoring for hospitals
was a barrier to following the NICE guidelines [16,44]. They reported that few hospitals
had the access to equipment, while even fewer utilised the imaging where required. This
suggests that training should be an area for improvement. A study conducted in 2001
reported that only 63% (33/52) of hospitals had on-site access to EEG services, while 35%
(18/52) had emergency services [66]. This supports the finding that there is a lack of access
to imaging services [44]. However, there are no data available on patient characteristics
in relation to access to service; therefore, further research should be conducted. Another
study assessed the number of patients being misdiagnosed as a result of the lack of access
to specialist services and physicians [67]. This highlighted that 26.1% of patients were
misdiagnosed, and, as a result, mistreated, having possible socio-economic and health
impacts.
4.6. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Although CIDP is more common in men [17], this study could have included a greater
diversity of patients, as only 31.6% of the patients were women [45]. This would allow
for a better indication of how clinical representation factors into delays in diagnosis, as
suggested in this study.
It is suggested that delays could also be a result of bias at referral or a lack of commu-
nication between specialist and secondary clinics. As this is an avoidable issue, it could
be beneficial to increase awareness of symptoms of CIDP and the clinical presentation
of disease in patients. The lack of public awareness could have an impact on the rate of
misdiagnosis.
Misdiagnoses were recognised after a hospital stay or further patient relapse, high-
lighting the vulnerable position patients are left in if they have the wrong diagnosis and no
access to the required treatment. Delays in diagnosis could lead to axonal loss and limit
treatment options for the patient. This, therefore, underlines the urgency of utilising imag-
ing techniques such as MRI. Furthermore, this would be more reliable and cost-effective
than depending on presentation of disease, which varies from patient to patient.
4.7. Parkinson’s Disease (PD)
This study identified that there are patterns in the data between delays and patient
characteristics [46], such as age and education, showing that patient characteristics can
affect diagnosis and referral. Treating patients before a diagnostic assessment can put them
Int. J. Environ. Res. Public Health 2021, 18, 10633 22 of 27
at risk of further harm, showing that risks are not the same for all patients even while being
treated in a public health care system. It was also identified that patients not having access
to specialist care from neurologists is in breach of the NICE guidelines for PD [18]. As
identified by the authors of the study, further research is needed to see if these findings are
replicated across other regions of the U.K.
4.8. Inequalities in Access to Diagnostic Neuroimaging Facilities
Overall, the studies highlight that there is a delay in accessing neuroimaging facilities
[14,33,34,37,39,43,46]. This is further emphasised by the lower cognitive scores in BAME
patients diagnosed with dementia, indicating that there is an average ratio 1.41:1 of BAME
patients having a lower MMSE score when compared to White patients [5,32,46]. MMSE is
used as an indication of disease progression; therefore, a lower score at diagnosis suggests
a delay in referral to neuroimaging services. It is suggested that the delays in referral are
due to lack of GP referrals in more deprived areas and the delayed help-seeking behaviours
in minority communities [34,37,51–54].
(1) Level of deprivation measured in Townsend scores in North England for emergency
CT neuroimaging [39]. Least deprived (n = 4078) is in the highest quantile and most
deprived (n = 6395) is in the lowest quantile. A score above 1 highlights more patients in
deprived areas accessing neuroimaging for head traumas. It is suggested the increased
need is due to socio-economic factors such as risk-associated behaviours and manual labour
occupations [39]. (2) High levels of deprivation measured by Carstair scores result in less
precautionary same-day CT or MRI imaging of patients admitted with stroke management
in English public hospitals [14]. The total number of scans in 2008/09 was 25452). A score
below 1 indicates that fewer precautionary CT and MRI scans are taken for patients in
lower quartiles of socio-economic deprivation at request of health care professionals. (3)
High levels of deprivation measured in IMD scale indicate fewer numbers of referred cases
of dementia by GP practices, taking Stockport (n = 293,594) and Manchester (n = 531,153)
as examples of the least and most deprived regions in the area, respectively [34]. A score
below 1 indicates an underdiagnosis of dementia patients in more deprived areas. (4)
Level of deprivation specified by the Index of Multiple Deprivation’s (IMD) 2004 ranking
against the patients presenting with late stage oral cancer in Liverpool [15] (most deprived
(n = 351/711) against least deprived (n = 310/711)). A score above 1 indicates that more
patients in the least deprived areas have a delayed diagnosis of oral cancer. (5) Level of
education attainment as an index of socio-economic status is inversely proportional to cases
of upper aerodigestive tract cancer in Glasgow, Manchester and Newcastle (n = 322) [43].
A score above 1 indicates how groups with a lower education attainment have higher rates
of cancer presentation. (6) GP referrals of BAME patients to Memory Assessment Services
(MAS) for dementia against White patients in London (n = 628,730) [37]. BAME patients
are more socio-economically deprived and, therefore, this is a measure against White
patients, who are representative of less deprived groups [56]. A score below 1 indicates an
underrepresentation of BAME at MAS clinics due to the lack of referrals to access specialist
diagnostic services. (7) Diagnostic Mini Mental State Examination scores as a measure
of dementia progression at the time of diagnosis in BAME patients against White British
patients in London (n = 13,233) [33]. A score below 1 indicates a delayed referral to MAS
compared to White patients. Delayed referral highlights an inequality that may be due to
delayed help-seeking behaviours in ethnic minority communities [51–54].
4.9. Strengths and Limitation
The main strength of this study is that it compares the difference in socio-economic
factors between all regions of the U.K., whereas other studies have focused on patient
demographic differences as a whole. This addresses the inconsistencies in CCGs in local
areas and the differences in patient access to services.
Limitations of this study include the lack of data available on health inequalities in
diagnostic neurology. It is suggested that this should be an area for further research to see
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if these findings can be replicated with other neurological diseases or other neuroimaging
techniques. It would be a research point of interest to investigate the accessibility of more
expensive, specialist imaging equipment, as CT, MRI, ultrasound and EEG are routinely
used.
Patient numbers of BAME communities is lower in areas of the U.K. where BAME
are underrepresented [32,36], meaning that it is difficult to identify a pattern with the data
collected in this study in order to conclude that these patients face a significant delay in
diagnosis. This could also be a factor of the lack of minority communities’ engagement in
research [68].
5. Conclusions
Our study has found that there is an association between the lack of access to diag-
nostic neuroimaging facilities and a patient’s socio-economic status from the evidence
presented in the papers that were included in this study (Figure 3). Although there is a
greater prevalence of disease associated with depravation, meaning that there is a greater
number of patients of BAME communities seeking medical attention, there are also data to
suggest that there is still under-representation in some areas of the U.K. This study shows
how there is a higher disease progression of dementia and PD at diagnosis in patients of a
lower SES, which could suggest delays in access to diagnostic treatment from GP referrals;
therefore, this research area should be further explored.
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Figure 3. Analysis of some exemplar studies indicating the rel ship between social deprivation factors and health care
service provisions.
There is no conclusive evidence of disparities in relation to MRI, ultrasound or EEG
imaging specifically from the available data, highlighting insufficient research in these
areas. Data currently v ilable on CT imaging has i dicated that utilisation may not be the
most effective in some cases. For example, MRI should be used instead of CT imaging for
stroke managem nt. This outcome supports the idea suggested in a recent BMJ article [26].
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This state of poor quality of patient care could contribute to more mortality rates than the
lack of access to services. Further research should be conducted on the appropriate use of
imaging techniques to determine if this has an overall effect on morbidity and mortality
rates of patients undergoing stroke care. In addition to this, the lack of data available on
EEG imaging access for emergency service is a concern. Further research should identify
the implications for lack of equipment in hospitals and possible suggestions to improve
the services.
Although this study is exclusive to the U.K., it is clear that there are similar inequalities
in Europe and America [12,43]. Therefore, a comparative study of health inequities in
respect to access to diagnostic neuroimaging facilities should be conducted as a future
research interest to highlight the global impact of health inequalities.
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